Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

6.59
+2.0344.52%
Pre-market: 6.53-0.0600-0.91%05:37 EDT
Volume:46.39M
Turnover:330.95M
Market Cap:3.90M
PE:-0.06
High:8.60
Open:7.72
Low:6.13
Close:4.56
52wk High:202.50
52wk Low:4.56
Shares:592.37K
Float Shares:532.20K
Volume Ratio:833.26
T/O Rate:8717.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3536
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:1.04
PE(LYR):-0.05

Loading ...

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Yesterday

BioAffinity Technologies advances CyPath Lung for cancer survivor surveillance

TIPRANKS
·
Yesterday

bioAffinity Advances CyPath Lung Test for Post-Treatment Lung Cancer Surveillance

Reuters
·
Yesterday

bioAffinity Technologies Advances Cypath® Lung for Surveillance of Lung Cancer Survivors

THOMSON REUTERS
·
Yesterday

NASDAQ Trade Halt Continues Reason not Available at 03:58 Am

Reuters
·
Aug 24

bioAffinity Technologies Inc trading halted, news pending

TIPRANKS
·
Aug 22

bioAffinity Technologies Effects 1-for-15 Reverse Stock Split Effective Aug. 24, 2026

Reuters
·
Aug 20

bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026

THOMSON REUTERS
·
Aug 20

bioAffinity Signs AvMEDICAL Distribution Deal for CyPath Lung in Federal Healthcare Market

Reuters
·
Aug 18

bioAffinity Technologies and Avmedical Announce Nationwide Federal Healthcare Distribution Agreement for Cypath® Lung

THOMSON REUTERS
·
Aug 18

BioAffinity Technologies announces closing of $4M private placement offering

TIPRANKS
·
Aug 16

bioAffinity Technologies Closes $4 Million Private Placement of Pre-Funded Warrants Priced at $0.47

Reuters
·
Aug 14

bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Aug 14

bioAffinity Technologies Prices USD 4 Million Private Placement at USD 0.47 Per Share Unit

Reuters
·
Aug 13

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Aug 13

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Reuters
·
Aug 10

bioAffinity Technologies Q2 Net Income USD -3.4 Million

THOMSON REUTERS
·
Aug 07

bioAffinity Technologies Q2 EPS $(0.64) Beats $(2.40) Estimate, Sales $1.511M Beat $1.483M Estimate

Benzinga Earnings
·
Aug 07

bioAffinity Q2 FY26 Net Loss Narrows to $3.4 Million; Revenue Rises 19% to $1.5 Million

Reuters
·
Aug 07

Press Release: bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung

Dow Jones
·
Aug 07